RSRalph Thomas Schär

Ralph Thomas Schär

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ralph Thomas Schär has a total of 229 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantitative MRI techniques for measuring fatty infiltration in the lumbar paraspinal muscles: a systematic review

    by Carla M. Zihlmann, Ada Ayechu Abendaño, Sudeesh Arputham Dass, Mirko Blättler, McKinley Van Klei, Christoph E. Albers, Moritz C. Deml, Johannes T. Heverhagen, Ralph T. Schär, Keivan Daneshvar, et al.

    Background: Fatty infiltration of the lumbar paraspinal muscles has been associated with spine degeneration and is widely studied in relation to spinal disorders. Assessment of muscle fat content using magnetic resonance imaging (MRI) provides a clinically practical and non-invasive method for these studies. However, considerable methodological heterogeneity exists in the MRI-based approaches used to quantify muscle fat, and a comprehensive overview of these approaches is lacking. Therefore, this systematic review aims to summarize the MRI sequences, muscle segmentation and fat quantification methods used in research studies investigating lumbar spinal musculature and to highlight current applications of machine-learning methods in this context. Methods: A systematic search was conducted on PubMed, Web of Science, and Scopus in October 2025. All retrieved publications were screened according to predefined inclusion and exclusion criteria. Relevant information regarding imaging sequences, fat quantification methods, method reliabilities and participant characteristics was extracted from the included studies. Results: Of the 280 MRI sequence applications identified across the 274 included publications, 209 (75%) used either T1-weighted imaging (T1WI) or T2-weighted imaging (T2WI), while the remaining sequence applications were based on chemical-shift (CS) MRI techniques. Manual segmentation was the predominant approach for outlining the muscles of interest. Only a small number of studies used machine learning approaches for segmentation and fat quantification, with the U-Net architecture being the most common. For T1WI/T2WI images, several methods were used to quantify fatty infiltration within the muscles, including different thresholding approaches, signal-intensity measures, and manually outlining fat tissue. Reported reliabilities for fat quantification methods using T1WI/T2WI images varied across studies and were reported inconsistently. CS techniques most frequently used the 6-point Dixon method, followed by 2-point and 3-point Dixon methods for determining fatty infiltration. Studies using T1WI/T2WI images mainly investigated populations with degenerative lumbar pathologies, while the cohort who underwent CS MRI included both healthy and diseased participants. Conclusions: T2WI MRI was the most commonly used imaging technique for assessing fatty infiltration of the lumbar paraspinal muscles, although the applied fat quantification methods vary and lack validation. Therefore, standardized and validated T2WI protocols are urgently needed to improve clinical utility and comparability across studies. In contrast, CS-based techniques provide a quantitative approach based on the difference in resonance frequencies between water and fat proton signals but remain less commonly used in clinical research. Future studies should focus on developing more reliable automated approaches for muscle segmentation to reduce manual workload.

  • Open Access

    The MSI-20 Score Provides Reproducible Mortality Risk Stratification in Spinal Infection: A Multicenter Registry Study and External Validation

    by Sara Lener, Raphael Gmeiner, Anto Abramovic, Anna Koller, Christoph Orban, Sebastian Hartmann, Alexandra Grob, Victor Staartjes, Ann Kathrin Joerger, Carolin Albrecht, et al.

    Objective: Spinal infection (SI) is associated with substantial morbidity and mortality, and optimal treatment strategies remain debated, particularly in medically fragile patients. The Mortality in Spinal Infection (MSI-20) score was developed as the first dedicated prognostic tool for mortality risk estimation, but external validation in large cohorts has been lacking. This study aimed to externally validate the MSI-20 in a large multicenter registry cohort and assess its performance, clinical thresholds, and generalizability.Methods: This retrospective multi-institutional registry study included 1,122 adult patients with clinically, radiologically, and laboratory-confirmed SI treated at 6 tertiary referral centers between 2010 and 2023. The multicenter registry design enabled robust analysis of this relatively rare outcome. MSI-20 scores were calculated according to the original definition. Predictive performance was evaluated using receiver operating characteristic (ROC) analysis with 95% confidence intervals. Mortality across score strata and center-wise performance were analyzed, with exploratory assessment of additional baseline predictors.Results: Mean age was 66.4±13.1 years, and overall mortality was 18.3%. The MSI-20 demonstrated fair discriminative ability (area under the curve [AUC], 0.68; 95% confidence interval [CI], 64–72). The optimal ROC threshold was 3.5; a cutoff ≥4 yielded sensitivity 0.49 and specificity 0.74 (F1 score, 0.38). Mortality increased progressively, approaching 50% (47.4%) at scores ≥9. Performance was consistent across centers (AUC, 0.60–0.75). Exploratory univariable analyses did not identify additional baseline variables with consistent strong associations beyond the MSI-20 components.Conclusion: This large multicenter registry study provides the first external validation of the MSI-20, confirming reproducibility and generalizability. The score demonstrated fair discrimination and a clear risk gradient across increasing score categories. Given its simplicity and high negative predictive value, the MSI-20 may serve as an adjunctive tool to support risk communication, multidisciplinary discussion, patient counseling, and preoperative optimization in spinal infection.


  • Open Access

    Swiss national spinal implant registry SIRIS Spine: methods and first results

    by Thorsten Jentzsch, David Bellut, Ralph T. Schär, Daniel Haschtmann, Emin Aghayev


  • Kurzlehrbuch Neurologie

    by Heinrich Mattle, Simon Jung, Urs Fischer, Rike Barth, Tatiana Brémovà-Ertl, Lara Chilver-Stainer, Tomas Dobrocky, Bogdan Draganski, Eveline Hofmann, Robert Höpner, et al.

  • Open Access

    Intrawound vancomycin powder for prevention of surgical site infections after open instrumented posterior spinal fusion (VANCO Trial)—methodology of a randomized, controlled, multicenter study

    by Ralph T. Schär, Mattia Branca, Urs Fischer, Stefan Zimmerli, Nicole Söll

    Surgical site infections (SSIs) after instrumented spine fusion surgery may occur in up to 12% of cases and lead to increased morbidity, mortality, and healthcare costs. Numerous retrospective studies suggest the use of intrawound vancomycin powder in spine surgery to be protective against SSIs. The use of intrawound vancomycin powder is controversial, and there is a paucity of well-designed prospective trials evaluating its safety and efficacy in spine surgery. The objective of the VANCO Trial is to evaluate the safety and efficacy of intrawound vancomycin powder in open instrumented spine fusion surgery to prevent SSIs. The VANCO Trial is a multicenter, 1:1 randomized superiority trial with a total of 7 recruiting spine institutions in Switzerland. Adult patients scheduled for an open spinal fusion procedure will be screened for eligibility. Randomization of participants will take place intraoperatively before wound closure. Patients randomized into the treatment arm will receive 1–2 g of vancomycin powder (depending on length of skin incision: ≤ 20 cm vs. > 20 cm), which will be administered above the closed muscle fascia (suprafascially-subcutaneously) before wound closure. The main outcome and measure is the rate of superficial and deep SSIs within 90 days following surgery. The VANCO Trial is one of the first clinical trials to evaluate the safety and efficacy of intrawound vancomycin powder in a selected spine surgery population. Routine administration of intrawound vancomycin powder in selected spine surgery patients could fundamentally advance international standards for reducing SSIs. ClinicalTrials.gov NCT04017468.


  • Open Access

    The utility of preoperative computed tomography-guided screw marking in thoracic spine surgery

    by Christopher Marvin Jesse, Aatharshan Kannathasan, Ralph T. Schär, Johannes Goldberg, Andreas Raabe, Jan Gralla, Johannes Kaesmacher, Tomas Dobrocky, Eike Immo Piechowiak

  • Open Access

    Treatment practices for geriatric type II odontoid fractures – A survey by the European Association of Neurosurgical Societies Spine Section

    by Ralph T. Schär, Jefferson R. Wilson, Marcel Ivanov, Giuseppe Barbagallo, Yana Petrova, Carla Reizinho, Maria Luisa Gandia González, Enrico Tessitore, Andrzej Maciejczak, Nikolay Gabrovsky, et al.

  • Open Access

    Minimally Invasive Transdural Closure of a Ventral Spinal Cerebrospinal Fluid Leak in Spontaneous Intracranial Hypotension: 2-Dimensional Operative Video

    by Levin Häni, Christopher Marvin Jesse, Tomas Dobrocky, Eike Immo Piechowiak, Ralph Thomas Schär, Andreas Raabe


  • Open Access

    Diagnosis and management of de novo non-specific spinal infections: European Association of Neurosurgical Societies (EANS) Spine Section Delphi consensus recommendations

    by Andreas Kramer, Santhosh G. Thavarajasingam, Jonathan Neuhoff, Benjamin Davies, Giuseppe Barbagallo, Bertrand Debono, Bart Depreitere, Sven O. Eicker, Nikolay Gabrovsky, Marisa L. Gandia-Gonzalez, et al.


  • Open Access

    Research productivity on spontaneous intracranial hypotension: A bibliometric analysis

    by Christopher Marvin Jesse, Nicolas W. Graf, Levin Häni, Johannes Goldberg, Tomas Dobrocky, Eike I. Piechowiak, Andreas Raabe, Ralph T. Schär